Merck Launches New Addition to the Circumvent G2 Product Line

US - Merck Animal Health last week introduced Circumvent® PCV-M G2 - a porcine circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae combination vaccine. The new vaccine is the only one-dose or two-dose, ready-to-use combination with five-month PCV2 duration of immunity, which is 25 percent longer than any other PCV2 vaccine on the market.
calendar icon 23 January 2014
clock icon 2 minute read
© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.